Health News
Lung Cancer Rx Might Outperform Chemo
When you're sick, you may feel like the immune system is a weak tool for protecting the body. But new evidence is showing how medications might activate the immune system to treat a very serious illness — lung cancer.
Trial on Bristol-Myers Squib Drug Stopped Early
Bristol-Myers Squibb Company (NYSE:BMY) today announced that an open-label, randomized Phase 3 study evaluating Opdivo versus docetaxel in previously treated patients with advanced, squamous cell non-small cell lung cancer (NSCLC) was stopped early.
Good To The Bone
When lung cancer starts to spread, it often goes to the bone. This is the site of metastasis (spread) for other cancers as well. A comparison of bone medications found one to be superior.